Brobeck, Phleger & Harrison
3
6M
3
1
- Areas of investment
Summary
Among the most popular portfolio startups of the fund, we may highlight PrimeOne Solutions, Panacea Pharmaceuticals, Vertical Networks. Among the most successful fund investment fields, there are Communications Infrastructure, Health Care. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
This Brobeck, Phleger & Harrison works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2004. The high activity for fund was in 2000. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Brobeck, Phleger & Harrison, startups are often financed by Van Wagoner Ventures, LLC, TCV, Kleiner Perkins. The meaningful sponsors for the fund in investment in the same round are Van Wagoner Ventures, LLC, TCV, Spring Creek Investment Management, LLC. In the next rounds fund is usually obtained by SoftBank, Mitsubishi International Corporation (MIC), MedImmune Ventures.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Text Analytics (1)
- Developer Tools (1)
- Developer Platform (1)
- Biotechnology (1)
- Pharmaceutical (1) Show 3 more
- Investments by region
-
- United States (2)
- United Kingdom (1)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Avg. valuation at time of investment
- 6M
- Group Appearance index
- 0.67
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Panacea Pharmaceuticals | 27 Sep 2000 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 0 | United States, Maryland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.